JP2008506407A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506407A5
JP2008506407A5 JP2007521881A JP2007521881A JP2008506407A5 JP 2008506407 A5 JP2008506407 A5 JP 2008506407A5 JP 2007521881 A JP2007521881 A JP 2007521881A JP 2007521881 A JP2007521881 A JP 2007521881A JP 2008506407 A5 JP2008506407 A5 JP 2008506407A5
Authority
JP
Japan
Prior art keywords
sequence
seq
detecting
group
distinguishing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007521881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008506407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/007830 external-priority patent/WO2006008128A2/en
Publication of JP2008506407A publication Critical patent/JP2008506407A/ja
Publication of JP2008506407A5 publication Critical patent/JP2008506407A5/ja
Pending legal-status Critical Current

Links

JP2007521881A 2004-07-18 2005-07-18 乳房細胞増殖性疾患を検出するためのエピジェネティックな方法および核酸 Pending JP2008506407A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04016926 2004-07-18
PCT/EP2005/007830 WO2006008128A2 (en) 2004-07-18 2005-07-18 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders

Publications (2)

Publication Number Publication Date
JP2008506407A JP2008506407A (ja) 2008-03-06
JP2008506407A5 true JP2008506407A5 (OSRAM) 2008-09-25

Family

ID=35462310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007521881A Pending JP2008506407A (ja) 2004-07-18 2005-07-18 乳房細胞増殖性疾患を検出するためのエピジェネティックな方法および核酸

Country Status (4)

Country Link
US (2) US20090298054A1 (OSRAM)
EP (4) EP2281902A1 (OSRAM)
JP (1) JP2008506407A (OSRAM)
WO (1) WO2006008128A2 (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1877577A2 (en) * 2005-04-15 2008-01-16 Epigenomics Inc. Methods and nucleic acids for analyses of cellular proliferative disorders
JP2007267700A (ja) * 2006-03-31 2007-10-18 Kochi Univ Ｈｏｘｂ１３遺伝子のメチル化を指標とする腎細胞癌を含む悪性腫瘍の判定方法
JP5323680B2 (ja) * 2006-04-17 2013-10-23 エピゲノミクス アーゲー 結腸直腸細胞増殖性疾患を検出するための方法および核酸
US20090317810A1 (en) * 2006-04-17 2009-12-24 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
US20100143902A1 (en) * 2006-07-21 2010-06-10 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
WO2008009479A1 (en) * 2006-07-21 2008-01-24 Epigenomics Ag Methods and nucleic acids for analyses for cellular proliferative disorders
EP2258871B1 (en) * 2007-01-19 2014-05-14 Epigenomics AG Methods and nucleic acids for analyses of cell proliferative disorders
US9096849B2 (en) * 2007-05-21 2015-08-04 The United States Of America, As Represented By The Secretary Of The Navy Solid phase for capture of nucleic acids
CN101861398A (zh) * 2007-09-17 2010-10-13 皇家飞利浦电子股份有限公司 用于乳腺癌紊乱分析的方法
CA2708163A1 (en) * 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
WO2009074364A1 (en) * 2007-12-13 2009-06-18 Edgar Dahl Novel prognostic breast cancer marker
CA2718092C (en) 2008-03-21 2019-03-19 Oncomethylome Sciences S.A. Detection and prognosis of cervical cancer
JP2009247260A (ja) * 2008-04-04 2009-10-29 Sumitomo Chemical Co Ltd Ｄｎａメチル化測定方法
US20100112643A1 (en) * 2008-11-04 2010-05-06 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Method for direct capture of ribonucleic acid
KR20110113642A (ko) * 2009-01-30 2011-10-17 코닌클리케 필립스 일렉트로닉스 엔.브이. 유방 종양의 하위분류 방법
EP2428584A4 (en) * 2009-04-03 2012-10-10 A & T Corp COLORECTAL TUMOR DETECTION METHOD
WO2010118782A1 (en) * 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
JP5986746B2 (ja) * 2009-06-30 2016-09-06 シスメックス株式会社 生体試料中の上皮性癌由来の細胞の存否を判定するための方法、分子マーカー及びキット
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
WO2011105570A1 (ja) 2010-02-26 2011-09-01 シスメックス株式会社 生体試料中の癌細胞の存否を判定する方法、判定用分子マーカーおよびキット
JP5636611B2 (ja) * 2010-02-26 2014-12-10 株式会社明治 消化管癌に対する発癌リスク抑制効果の評価方法
JP5932778B2 (ja) * 2010-05-28 2016-06-15 ビオメリューＢｉｏｍｅｒｉｅｕｘ 乳癌と良性乳房疾患を識別するための方法及びキット
EP2505665A1 (en) * 2011-03-31 2012-10-03 Queen Mary And Westfield College, University Of London Cancer markers
US20130309667A1 (en) * 2012-05-15 2013-11-21 Anthony P. Shuber Primers for analyzing methylated sequences and methods of use thereof
US9976187B2 (en) 2012-06-13 2018-05-22 King Abdullah University Of Science And Technology Methylation biomarkers for prostate cancer
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
CA2914685A1 (en) 2013-06-24 2014-12-31 Mirna Therapeutics, Inc. Biomarkers of mir-34 activity
ES2695179T3 (es) * 2014-12-05 2019-01-02 Epiontis Gmbh Procedimiento epigenético para la identificación de linfocitos T auxiliares foliculares (THF)
JP2017090103A (ja) * 2015-11-05 2017-05-25 和光純薬工業株式会社 非浸潤性乳癌の判定法
JP2017090102A (ja) * 2015-11-05 2017-05-25 和光純薬工業株式会社 浸潤性乳癌の判定法
EP3481296A1 (en) * 2016-07-08 2019-05-15 Ontolead, Inc. Relationship analysis utilizing biofeedback information
WO2018048354A1 (en) * 2016-09-07 2018-03-15 Agency For Science, Technology And Research A method of identifying risk of cancer and therapeutic options
CN107267597A (zh) * 2017-03-10 2017-10-20 王建华 Hic1在肿瘤诊断、治疗、预后和预测复发中的应用
CN111095263A (zh) * 2017-06-26 2020-05-01 纽约州立大学研究基金会 用于虚拟胰造影术的系统、方法和计算机可访问介质
JP7072825B2 (ja) * 2017-09-13 2022-05-23 三菱電機ソフトウエア株式会社 コピー数計測装置、コピー数計測プログラムおよびコピー数計測方法
EP3828289A4 (en) * 2018-07-26 2022-06-08 Excellen Medical Technology Co., Ltd. METHOD AND KIT FOR IDENTIFYING A GASTRONIC CANCER CONDITION
EP3828290A4 (en) * 2018-07-26 2022-03-23 Excellen Medical Technology Co., Ltd. Method for identifying state of breast cancer and kit
CN110055330B (zh) * 2019-04-30 2022-10-11 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep9及其应用
WO2020252721A1 (en) * 2019-06-20 2020-12-24 The Johns Hopkins University Dna methylation markers and their use in differentiation of suspected cancerous lymph node biopsy samples
KR102637032B1 (ko) * 2020-01-28 2024-02-15 주식회사 젠큐릭스 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도
WO2025212993A1 (en) * 2024-04-05 2025-10-09 Encoded Therapeutics, Inc. Materials and methods for trangene expression in neural cells

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
CA2177031A1 (en) 1993-11-30 1995-06-08 Moshe Szyf Inhibition of dna methyltransferase
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
AU7829398A (en) 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
WO2002002806A2 (en) * 2000-06-30 2002-01-10 Epigenomics Ag Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics
AU1218802A (en) * 2000-09-01 2002-03-13 Epigenomics Ag Method for determining the degree of methylation of defined cytosines in genomicdna in the sequence context 5'-cpg-3'
DE10112515B4 (de) 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
AU2003250989A1 (en) * 2002-08-27 2004-03-19 Epigenomics Ag Method and nucleic acids for the analysis of breast cell proliferative disorders
AU2004237861B2 (en) * 2003-12-11 2010-04-29 Epigenomics Ag Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients

Similar Documents

Publication Publication Date Title
JP2008506407A5 (OSRAM)
US11840739B2 (en) Gene composition for detecting cell proliferative abnormality or grading disease degree and use thereof
JP7000504B2 (ja) 結腸直腸癌のためのメチル化マーカー
JP2024123233A5 (OSRAM)
JP2023025184A5 (ja) メチル化ｄｎａの分析による腫瘍の検出
JP2025041764A5 (OSRAM)
JP2020506680A5 (OSRAM)
CN102311953B (zh) 尿液诊断膀胱癌的方法和试剂盒
EP3083993B1 (en) Gene methylation based colorectal cancer diagnosis
WO2018087129A1 (en) Colorectal cancer methylation markers
WO2016101258A1 (zh) 一种检测与人体异常状态相关的差异甲基化CpG岛的方法
US20100081145A1 (en) Detecting Prostate Cancer
JP2010516234A5 (OSRAM)
JP2009533066A5 (OSRAM)
US6858388B2 (en) Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA
HRP20140692T1 (hr) Postupci i nukleinske kiseline za analizu poremeä†aja proliferacije stanica
CN105452485A (zh) 用于检测癌前病损的方法
JP2005518798A (ja) マイクロサテライト不安定性の検出のためのモノヌクレオチド反復マイクロサテライトマーカー
EP3430162A1 (en) Methylation markers for pancreatic cancer
CN110484621B (zh) 一种肝癌早期预警的方法
US20220177973A1 (en) Methylation modification-based tumor marker stamp-ep6
US20110245087A1 (en) Method for optimizing and validating an assay for determining the presence or absence of a medical condition
KR20100105770A (ko) 전립선암에서 ｇｓｔｐ１ 과메틸화의 검출
US11535897B2 (en) Composite epigenetic biomarkers for accurate screening, diagnosis and prognosis of colorectal cancer
WO2005021743A1 (ja) 核酸増幅用プライマー及びこれを用いた大腸癌の検査方法